Annika Kim Constantino

The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning!

A CVS in Las Vegas has become the first location to join a new national pharmacy union , a milestone as organizers try to help thousands of U.S. pharmacy workers address what they call unsafe working conditions

A federal judge in New Jersey on Monday rejected Johnson & Johnson and Bristol Myers Squibb 's legal challenges to the Biden administration's Medicare drug price negotiations , ruling that the program is constitutional.

The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name

Johnson & Johnson on Wednesday said it will pay $6.5 billion to resolve nearly all lawsuits in the U.S. claiming its talc-based products caused ovarian cancer.

AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group's CEO will testify on Capitol Hill.

Amgen 's stock rose more than 12% on Friday after t he drugmaker teased positive initial data on its experimental weight loss injection.

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.

Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies.